|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-3-26
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Most patients with hypertension require antihypertensive combination therapy to achieve BP control. This study investigated the safety and efficacy of the direct renin inhibitor aliskiren combined with the calcium channel blocker amlodipine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
951-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19257800-Adult,
pubmed-meshheading:19257800-Aged,
pubmed-meshheading:19257800-Amides,
pubmed-meshheading:19257800-Amlodipine,
pubmed-meshheading:19257800-Antihypertensive Agents,
pubmed-meshheading:19257800-Blood Pressure,
pubmed-meshheading:19257800-Diastole,
pubmed-meshheading:19257800-Drug Therapy, Combination,
pubmed-meshheading:19257800-Drug Tolerance,
pubmed-meshheading:19257800-Female,
pubmed-meshheading:19257800-Fumarates,
pubmed-meshheading:19257800-Humans,
pubmed-meshheading:19257800-Hypertension,
pubmed-meshheading:19257800-Male,
pubmed-meshheading:19257800-Middle Aged,
pubmed-meshheading:19257800-Patient Selection,
pubmed-meshheading:19257800-Safety,
pubmed-meshheading:19257800-Systole
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.
|
|
pubmed:affiliation |
Piedmont Medical Research Associates, Winston-Salem, NC 27103, USA. TWLittlejohn@pmg-research.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
